Search Results - "Wolpert, Howard"

Optimized Mealtime Insulin Dosing for Fat and Protein in Type 1 Diabetes: Application of a Model-Based Approach to Derive Insulin Doses for Open-Loop Diabetes Management by Bell, Kirstine J, Toschi, Elena, Steil, Garry M, Wolpert, Howard A

“…To determine insulin dose adjustments required for coverage of high-fat, high-protein (HFHP) meals in type 1 diabetes (T1D). Ten adults with T1D received…”
Get full text

Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era by Bell, Kirstine J, Smart, Carmel E, Steil, Garry M, Brand-Miller, Jennie C, King, Bruce, Wolpert, Howard A

“…Continuous glucose monitoring highlights the complexity of postprandial glucose patterns present in type 1 diabetes and points to the limitations of current…”
Get full text

Dietary Fat Acutely Increases Glucose Concentrations and Insulin Requirements in Patients With Type 1 Diabetes: Implications for carbohydrate-based bolus dose calculation and intensive diabetes management by WOLPERT, Howard A, ATAKOV-CASTILLO, Astrid, SMITH, Stephanie A, STEIL, Garry M

“…Current guidelines for intensive treatment of type 1 diabetes base the mealtime insulin bolus calculation exclusively on carbohydrate counting. There is strong…”
Get full text

Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline by Peters, Anne L, Ahmann, Andrew J, Battelino, Tadej, Evert, Alison, Hirsch, Irl B, Murad, M. Hassan, Winter, William E, Wolpert, Howard

“…Objective: To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with…”
Get full text

Optimizing Glycemic Outcomes for Minoritized and Medically Underserved Adults Living with Type 1 Diabetes by Steenkamp, Devin W., Fantasia, Kathryn L., Wolpert, Howard A.

“…Individuals living with type 1 diabetes (T1D) from medically underserved communities have poorer health outcomes. Efforts to improve outcomes include a focus…”
Get full text

Defining continuous glucose monitor time in range in a large community-based cohort without diabetes by Spartano, Nicole L, Sultana, Naznin, Lin, Honghuang, Cheng, Huimin, Lu, Sophia, Fei, David, Murabito, Joanne M, Walker, Maura E, Wolpert, Howard A, Steenkamp, Devin W

“…Continuous glucose monitor (CGM) companies are beginning to market these sensors to populations without diabetes, but the range of CGM values clinicians should…”
Get full text

Severe hypoglycaemia while using a hybrid closed‐loop insulin pump system: A reminder of the continued importance of patient education for pre‐emptive hypoglycaemia mitigation by Steenkamp, Devin W., Piarulli, Amanda, Middelbeek, Roeland J. W., Wolpert, Howard A.

Get full text

Utility of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes by Toschi, Elena, MD, Wolpert, Howard, MD

“…A consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology held in February 2016 advocated expanding…”
Get full text

Health Care Transition in Patients With Type 1 Diabetes: Young adult experiences and relationship to glycemic control by GARVEY, Katharine C, WOLPERT, Howard A, RHODES, Erinn T, LAFFEL, Lori M, KLEINMAN, Ken, BESTE, Margaret G, WOLFSDORF, Joseph I, FINKELSTEIN, Jonathan A

“…To examine characteristics of the transition from pediatric to adult care in emerging adults with type 1 diabetes and evaluate associations between transition…”
Get full text

Continuous Glucose Monitoring — Coming of Age by Wolpert, Howard A

“…Advances in glucose-monitoring technology have been an important driver for improvements in the treatment of type 1 diabetes. The introduction of fingerstick…”
Get full text

Response to comment on: Wolpert et al. Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: implications for carbohydrate-based bolus dose calculation and intensive diabetes management. Diabetes Care 2013;36:810-816 by Wolpert, Howard A

Get full text

Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes by Rickels, Michael R, DuBose, Stephanie N, Toschi, Elena, Beck, Roy W, Verdejo, Alandra S, Wolpert, Howard, Cummins, Martin J, Newswanger, Brett, Riddell, Michael C

“…Patients with type 1 diabetes who do aerobic exercise often experience a drop in blood glucose concentration that can result in hypoglycemia. Current…”
Get full text

Nuts and Bolts of Achieving End Points With Real-Time Continuous Glucose Monitoring by Wolpert, Howard A

“…Real-time continuous glucose monitoring (RT-CGM) provides detailed information on glucose patterns and trends and promises to be a major advance in diabetes…”
Get full text

A daily study of stressors, continuously measured glucose, and diabetes symptoms in latinos with type 2 diabetes by Wagner, Julie, Armeli, Stephen, Tennen, Howard, Bermudez-Millan, Angela, Wolpert, Howard, Pérez-Escamilla, Rafael

“…This study examined whether daily stressors and continuously monitored glucose levels and glucose variability predict daily diabetes symptoms. Fifty Latinos…”
Get full text

Health care transition in young adults with type 1 diabetes: barriers to timely establishment of adult diabetes care by Garvey, Katharine C, Wolpert, Howard A, Laffel, Lori M, Rhodes, Erinn T, Wolfsdorf, Joseph I, Finkelstein, Jonathan A

“…To examine barriers to health care transition reported by young adults with type 1 diabetes and associations between barriers and prolonged gaps between…”
Get more information

Making sense of glucose sensors in end-stage kidney disease: A review by Williams, Mark E, Steenkamp, Devin, Wolpert, Howard

“…Diabetes mellitus remains the leading cause of end-stage kidney disease worldwide. Inadequate glucose monitoring has been identified as one of the gaps in care…”
Get full text

Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study by Hirsch, Irl B, Abelseth, Jill, Bode, Bruce W, Fischer, Jerome S, Kaufman, Francine R, Mastrototaro, John, Parkin, Christopher G, Wolpert, Howard A, Buckingham, Bruce A

“…The objective of the study was to evaluate the clinical effectiveness and safety of a device that combines an insulin pump with real-time continuous glucose…”
Get more information

Proof-of-concept Application of Continuous Glucose Monitoring Data Analytics to Identify Diabetes Glucotypes by Steenkamp, Devin W, Cheney, Michael C, Ju, Zhihui, Rodbard, David, Wolpert, Howard A

“…Abstract Background In this proof-of-concept study, we evaluated if monogenic diabetes resulting from mutations of the HNF-1α gene (HNF1A-MODY) has a…”
Get full text

Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial by Aiello, Lloyd Paul, Ayala, Allison R, Antoszyk, Andrew N, Arnold-Bush, Bambi, Baker, Carl, Bressler, Neil M, Elman, Michael J, Glassman, Adam R, Jampol, Lee M, Melia, Michele, Nielsen, Jared, Wolpert, Howard A

“…Optimization of glycemic control is critical to reduce the number of diabetes mellitus-related complications, but long-term success is challenging. Although…”
Get more information

Perceptions of Psychosocial Factors and the Insulin Pump by Ritholz, Marilyn D, Smaldone, Arlene, Lee, Jarim, Castillo, Astrid, Wolpert, Howard, Weinger, Katie

“…OBJECTIVE:--The purpose of this study was to identify psychosocial issues related to diabetes, approaches to self-care, self-perceptions, and social…”
Get full text